Comment: Fundamentals and Innovation in Antibiotic Trials

Click to increase image sizeClick to decrease image size

Acknowledgments

Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number UM1AI104681. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Additional information

Notes on contributors

Scott R. Evans

Scott R. Evans, Ph.D., Harvard School of Public Health, Harvard University, Boston, MA 02115 (E-mail: [email protected]). Dean Follmann, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), 6700B Rockledge Drive, Rm 5231, Bethesda, MD (E-mail: [email protected]).

Dean Follmann

Scott R. Evans, Ph.D., Harvard School of Public Health, Harvard University, Boston, MA 02115 (E-mail: [email protected]). Dean Follmann, Ph.D., National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), 6700B Rockledge Drive, Rm 5231, Bethesda, MD (E-mail: [email protected]).